Testing effectiveness (Phase 2)Study completedNCT00988858What this trial is testingAdvanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 55
Testing effectiveness (Phase 2)Looking for participantsNCT07636785What this trial is testingAnd 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsWho this might be right forHepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more VM Discovery, Inc. 111
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552What this trial is testingEvaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03149549What this trial is testingPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsWho this might be right forSolid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more CytomX Therapeutics 99
Not applicableLooking for participantsNCT01763125What this trial is testingEstablishment of a Tumor Bank for Blood SamplesWho this might be right forOvarian NeoplasmsBreast NeoplasmsColorectal Neoplasms+3 more Medical University of Vienna 10,000
Testing effectiveness (Phase 2)Study completedNCT02535338What this trial is testingErlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung CancerWho this might be right forRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7 National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565378What this trial is testingA Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 351
Testing effectiveness (Phase 2)Ended earlyNCT02584634What this trial is testingStudy to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)Who this might be right forNon-Small Cell Lung Cancer Pfizer 43
Testing effectiveness (Phase 2)UnknownNCT02775539What this trial is testingBeta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart FailureWho this might be right forPulmonary HypertensionMirabegronHeart Failure+1 more Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07633873What this trial is testingSYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）Who this might be right forNon-Small Cell Lung Cancer CSPC Megalith Biopharmaceutical Co.,Ltd. 500
Large-scale testing (Phase 3)Study completedNCT02486354What this trial is testingIcotinib in Advanced Metastatic Patients With NSCLC Previously Treated With ChemotherapyWho this might be right forNon-small Cell Lung Cancer Betta Pharmaceuticals Co., Ltd. 128
Large-scale testing (Phase 3)Study completedNCT00006229What this trial is testingPaclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer NCIC Clinical Trials Group 774
Testing effectiveness (Phase 2)Looking for participantsNCT06616766What this trial is testingA Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946Who this might be right forNSCLC (Non-small Cell Lung Cancer)Solid Tumor Yuhan Corporation 201
Early research (Phase 1)Study completedNCT00128622What this trial is testingDenileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+2 more H. Kim Lyerly 24
Testing effectiveness (Phase 2)Study completedNCT01561456What this trial is testingStudy of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungWho this might be right forNon-small-cell Lung CancerSquamous Cell CarcinomaAdenocarcinoma of the Lung Axelar AB 100
Early research (Phase 1)Active Not RecruitingNCT05334329What this trial is testingGenetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsWho this might be right forAdvanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+8 more University of California, Irvine 6
Large-scale testing (Phase 3)Looking for participantsNCT06216301What this trial is testingLUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCWho this might be right forMetastatic Non-small Cell Lung Cancer NovoCure GmbH 734
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600701What this trial is testingAtezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung CancerWho this might be right forMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaRefractory Lung Non-Small Cell Carcinoma+1 more National Cancer Institute (NCI) 53
Not applicableStudy completedNCT06686602What this trial is testingA Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast CancerWho this might be right forAdvanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer Daiichi Sankyo 13,759
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25